Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis

Annals of the Rheumatic Diseases

Volumn 69, Issue 5, 2010, Pages 924-927

  Holvast, Albert ^a   De Haan, Aalzen ^a   Van Assen, Sander ^a   Stegeman, Coen A ^a   Huitema, Minke G ^a   Huckriede, Anke ^a   Benne, Cornelis A ^b   Westra, Johanna ^a   Palache, Abraham ^c   Wilschut, Jan ^a   Kallenberg, Cees G M ^a   Bijl, Marc ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Laboratory for Infectious Diseases   (Netherlands)

^c Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 2; PREDNISONE; TUMOR NECROSIS FACTOR;

ADULT; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STAINING; WEGENER GRANULOMATOSIS;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; VACCINATION; WEGENER GRANULOMATOSIS;

EID: 77951564384     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.112813     Document Type: Article

References (16)

1. Kallenberg CG, Heeringa P, Stegeman CA. Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2006;2:661-670 (Pubitemid 44830855)
2. Phillip R, Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 2008;26(5 Suppl 51):S94-104.
3. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003;362:1733-1745
4. Influenza vaccines. Wkly Epidemiol Rec 2005;80:279-287
5. Zycinska K, Romanowska M, Nowak I, et al. Antibody response to inactivated subunit influenza vaccine in patients with Wegener's granulomatosis. J Physiol Pharmacol 2007;58(Suppl 5):819-828 (Pubitemid 351346731)
6. Holvast A, Stegeman CA, Benne CA, et al. Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination. Ann Rheum Dis 2009;68:873-878
7. McElhaney JE, Xie D, Hager WD, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006;176:6333-6339
8. McElhaney JE, Ewen C, Zhou X, et al. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009;27:2418-2425
9. Forrest BD, Pride MW, Dunning AJ, et al. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol 2008;15:1042-1053
10. Abdulahad WH, van der Geld YM, Stegeman CA, et al. Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. Kidney Int 2006;70:938-947
11. Berden AE, Kallenberg CG, Savage CO, et al. Cellular immunity in Wegener's granulomatosis: characterizing T lymphocytes. Arthritis Rheum 2009;60:1578-1587
12. Brouwer E, Stegeman CA, Huitema MG, et al. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 1994;98:448-453 (Pubitemid 24374730)
13. Popa ER, Franssen CF, Limburg PC, et al. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase. Arthritis Rheum 2002;46:1894-1904
14. Holvast A, van Assen S, de Haan A, et al. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Arthritis Rheum 2009;60:2438-2447
15. Vogt A, Mahé B, Costagliola D, et al. Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans. J Immunol 2008;180:1482-1489
16. Lindemann M, Witzke O, Lütkes P, et al. ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. Clin Immunol 2006;120:342-348 (Pubitemid 44175893)